Coyne Terrance P.

SEC CIK
0001814876

Latest role at each company

Trades

Every Form 4 that lists Coyne Terrance P. as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
RPRXRoyalty Pharma plcAug 17, 20265:01 PM ETAug 13, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−11K$58.6758−$645.55K0−100.0%SEC10b5-1
RPRXRoyalty Pharma plcMay 28, 2026May 26, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−64.4K$53.98−$3.48M0−100.0%SEC10b5-1
RPRXRoyalty Pharma plcApr 30, 2026Apr 28, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−34.79K$49.78−$1.73M40.14K−46.4%SEC10b5-1
RPRXRoyalty Pharma plcApr 2, 2026Apr 1, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−34.79K$48.33−$1.68M32.92K−51.4%SEC10b5-1
RPRXRoyalty Pharma plcMar 25, 2026Mar 23, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−34.79K$45.53−$1.58M43.89K−44.2%SEC10b5-1
RPRXRoyalty Pharma plcMar 4, 2026Mar 2, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−34.79K$46.7776−$1.63M45.76K−43.2%SEC10b5-1
RPRXRoyalty Pharma plcFeb 25, 2026Feb 23, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−34.79K$45.32−$1.58M47.64K−42.2%SEC10b5-1
RPRXRoyalty Pharma plcFeb 4, 2026Feb 2 – Feb 4, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−243.54K$42.5389−$10.36M22.89K−91.4%SEC10b5-1
RPRXRoyalty Pharma plcJan 23, 2026Jan 20, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.58K$39.35−$2.74M36.01K−65.9%SEC10b5-1
RPRXRoyalty Pharma plcJan 6, 2026Jan 2, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.58K$38.42−$2.67M39.76K−63.6%SEC10b5-1
RPRXRoyalty Pharma plcDec 17, 2025Dec 15, 2025Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.58K$38.36−$2.67M43.51K−61.5%SEC10b5-1
RPRXRoyalty Pharma plcDec 3, 2025Dec 1, 2025Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.58K$39.87−$2.77M47.26K−59.6%SEC10b5-1
RPRXRoyalty Pharma plcNov 26, 2025Nov 24, 2025Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.58K$38.5546−$2.68M51.01K−57.7%SEC10b5-1
RPRXRoyalty Pharma plcNov 19, 2025Nov 17, 2025Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−69.59K$39.30−$2.74M54.76K−56.0%SEC10b5-1
RPRXRoyalty Pharma plcAug 11, 2023Aug 9 – Aug 10, 2023Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−75K$30.735−$2.31M790K−8.7%SEC10b5-1
RPRXRoyalty Pharma plcJul 14, 2023Jul 12 – Jul 13, 2023Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−75K$31.00−$2.33M865K−8.0%SEC10b5-1
RPRXRoyalty Pharma plcNov 10, 2022Nov 8, 2022Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−24.5K$43.47−$1.07M940K−2.5%SEC
RPRXRoyalty Pharma plcNov 4, 2022Nov 2, 2022Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−5.5K$43.06−$236.83K964.5K−0.6%SEC
RPRXRoyalty Pharma plcAug 3, 2022Aug 1, 2022Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−30K$43.19−$1.3M970K−3.0%SEC